Displaying drugs 1626 - 1650 of 2773 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Olaparib | 434.4628 C24H23FN4O3 |  | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| Dacomitinib | 469.939 C24H25ClFN5O2 |  | A medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Afatinib | 485.938 C24H25ClFN5O3 |  | An antineoplastic agent used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with non-resistant EGFR mutations or resistance to platinum-based chemotherapy. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Mizolastine | 432.503 C24H25FN6O |  | A second-generation non-sedating antihistamine used to treat symptoms of allergic rhinoconjunctivitis and urticaria. | Histamine H1 Antagonists, Non-Sedating |
| Canagliflozin | 444.516 C24H25FO5S |  | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. | Glucosides / Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Thiophenes |
| Flavoxate | 391.4596 C24H25NO4 |  | A muscarinic antagonist and spasmolytic used for the symptomatic relief of conditions associated with lack of muscle control in the bladder, such as dysuria, urgency, and nocturia. | Drugs for Urinary Frequency and Incontinence |
| Nicergoline | 484.386 C24H26BrN3O3 |  | An ergot derivative use for the treatment of symptoms associated with cerebrovascular abnormalities. | Ergot Alkaloids and Derivatives |
| Sertindole | 440.941 C24H26ClFN4O |  | An atypical antipsychotic indicated in the treatment of schizophrenia. | Indole Derivatives |
| Fluvastatin | 411.473 C24H26FNO4 |  | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Heptanoic Acids / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia / Indoles |
| Carvedilol | 406.4742 C24H26N2O4 |  | A non selective beta-adrenergic antagonist used to treat mild to severe chronic heart failure, hypertension, and left ventricular dysfunction following myocardial infarction in clinically stable patients. | Alpha and Beta Blocking Agents |
| Mitapivat | 450.56 C24H26N4O3S |  | A pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency. | Sulfonamides |
| Olmesartan | 446.5016 C24H26N6O3 |  | An angiotensin receptor blocker (ARB) used in the treatment of hypertension. | Angiotensin II Antagonists and Calcium Channel Blockers / Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Pemigatinib | 487.508 C24H27F2N5O4 |  | A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| Iloperidone | 426.4806 C24H27FN2O4 |  | An atypical antipsychotic agent used for the acute treatment of schizophrenia in adults. | Agents that produce hypertension / Neurotoxic agents |
| Prenylamine | 329.4779 C24H27N |  | Prenylamine was withdrawn from the Canadian, US, and UK markets in 1988 due to concerns regarding cardiac arrhythmias. | Adrenergic Agents / Calcium Channel Blockers / Calmodulin, antagonists & inhibitors / Phenethylamines / Vasodilating Agents |
| Givinostat | 421.497 C24H27N3O4 |  | A histone deacetylase inhibitor indicated for the treatment of Duchenne Muscular Dystrophy (DMD). | Enzyme Inhibitors |
| Octocrylene | 361.485 C24H27NO2 |  | A sunscreen agent found in sunscreens that absorbs UV rays. | Sunscreen Agents |
| Troglitazone | 441.54 C24H27NO5S |  | For the treatment of Type II diabetes mellitus. It is used alone or in combination with a sulfonylurea, metformin, or insulin as an adjunct to diet and exercise. | Thiazolidinediones |
| Dimenhydrinate | 469.97 C24H28ClN5O3 |  | A medication used to prevent and treat nausea, vomiting, vertigo, and motion sickness. | Aminoalkyl Ethers |
| Tafenoquine | 463.501 C24H28F3N3O3 |  | An antiparasitic agent used for the treatment and prevention of relapse of Vivax malaria. | Aminoquinolines |
| Lumateperone | 393.506 C24H28FN3O |  | A novel 2nd generation antipsychotic used to manage both positive and negative symptoms in patients with schizophrenia. | Butyrophenone Derivatives |
| Ivacaftor | 392.4907 C24H28N2O3 |  | A cystic fibrosis transmembrane conductance regulator (CFTR) potentiator used alone or in combination products to treat cystic fibrosis in patients who have specific genetic mutations that are responsive to the medication. | Chloride Channel Agonists / Cystic Fibrosis Transmembrane Conductance Regulator Potentiators |
| Indacaterol | 392.4907 C24H28N2O3 |  | An inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. | Agents producing tachycardia / Agents that produce hypertension |
| Benazepril | 424.4895 C24H28N2O5 |  | An ACE inhibitor prodrug used to treat hypertension. | ACE Inhibitors and Calcium Channel Blockers / ACE Inhibitors and Diuretics |
| Bexarotene | 348.4779 C24H28O2 |  | A retinoid drug used for cutaneous manifestations of T-cell lymphoma in patients who have not responded well to previous systemic therapy. | Retinoids for cancer treatment |
Displaying drugs 1626 - 1650 of 2773 in total